Creating a better future for ultra-rare, one patient at a time.

Creating a better future for ultra-rare, one patient at a time.

mission

n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients with ultra-rare diseases (<30 patients).